Semgo Injections (Semaglutide)
Semgo Injection (Semaglutide) is an effective, once-weekly subcutaneous injection used to manage Type 2 Diabetes Mellitus (T2DM), promote sustainable weight loss, and reduce the risk of chronic kidney disease and major cardiovascular events. Available in progressive 0.25mg, 0.5mg, and 1mg pre-filled syringe doses, Semgo Injection mimics natural metabolic hormones to safely regulate long-term blood sugar, suppress appetite, and support overall cardio-renal and liver health.
Specifications
- 0.25MG
- Semgo Injection 0.25mg (Blue Box)
- 0.5MG
- Semgo Injection 0.5mg (Orange Box)
- 1MG
- Semgo Injection 1mg (Green Box)
AI Readiness
Good foundation, but some important product data is still missing.
70%